Italia markets closed

FTSE MIB
34.249,77
+310,02(+0,91%)
Dow Jones
38.282,55
+196,75(+0,52%)
Nasdaq
15.954,47
+342,71(+2,20%)
Nikkei 225
37.934,76
+306,28(+0,81%)
Petrolio
83,63
+0,06(+0,07%)
Bitcoin EUR
59.689,45
-666,35(-1,10%)

BSF Enterprise Plc (BSFA.L)

LSE - LSE Prezzo differito. Valuta in GBp (0.01 GBP).

Aggiungi a watchlist

5,25

+0,50

(+10,53%)

Alla chiusura: 03:22PM BST

Capitalizzazione	5,425M
Beta (5 anni mensile)	1,75
Rapporto PE (ttm)	N/D
EPS (ttm)	-0,02
Prossima data utili	N/D
Rendimento e dividendo (futuro)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update
LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, today provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues (3DBT). 3DBT's City-MixTM is a patented non-toxic culture media supplement that acts as an effective 'cell booster'. It is